Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Return on Assets: 2011-2025

Historic Return on Assets for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to -0.57%.

  • Myriad Genetics' Return on Assets fell 46.00% to -0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.57%, marking a year-over-year decrease of 46.00%. This contributed to the annual value of -0.12% for FY2024, which is 11.00% up from last year.
  • As of Q3 2025, Myriad Genetics' Return on Assets stood at -0.57%, which was down 21.39% from -0.47% recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Return on Assets ranged from a high of -0.01% in Q1 2022 and a low of -0.57% during Q3 2025.
  • Over the past 3 years, Myriad Genetics' median Return on Assets value was -0.21% (recorded in 2024), while the average stood at -0.23%.
  • Per our database at Business Quant, Myriad Genetics' Return on Assets grew by 15bps in 2021 and then plummeted by 46bps in 2025.
  • Over the past 5 years, Myriad Genetics' Return on Assets (Quarterly) stood at -0.02% in 2021, then dropped by 7bps to -0.09% in 2022, then decreased by 14bps to -0.23% in 2023, then rose by 11bps to -0.12% in 2024, then slumped by 46bps to -0.57% in 2025.
  • Its Return on Assets stands at -0.57% for Q3 2025, versus -0.47% for Q2 2025 and -0.10% for Q1 2025.